3M announces Solventum as name for planned independent healthcare company

3M announced Solventum will be the name of the planned, independent health care company following its spinoff. “This is another significant milestone on the path to building two-world class companies, 3M and Solventum,” said Mike Roman, 3M chairman and CEO. “We continue to prepare for the spin-off, and we’re committed to driving long-term value for shareholders.” The new name and branding will go into effect when the spin-off of the independent health care company occurs, which is expected in the first half of 2024, subject to final approval by 3M’s Board of Directors and other required conditions. Until the spin-off, the Health Care Business continues to be part of 3M and governed by the policies and procedures of 3M. 3M’s Health Care Business will continue to focus on markets such as: wound care, health care IT, oral care, filtration and purification, which resulted in $8.4B in sales in 2022.